TNFRSF9 and neoplasm: Pre-incubation with CD8 antibody suppressed the killing activity (Figure 5C) and we conclude that combined anti-TIM-3/CD137 mAbs elicited a tumor antigen-specific CTL response mediated by CD8+ T cells.